Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Advanced Immunod...

    2026-04-03

    Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Advanced Immunodetection for Translational Oncology

    Overview: Principle and Setup of the Cy3-Conjugated Secondary Antibody

    The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is an affinity-purified, polyclonal secondary antibody generated in rabbit and specifically designed to recognize both heavy and light chains of goat IgG. Conjugated with the robust fluorescent dye Cy3 (excitation max: 552 nm, emission max: 565 nm), it delivers high-intensity, photostable signals essential for sensitive immunodetection. APExBIO, the trusted supplier of this reagent, ensures rigorous immunoaffinity purification using antigen-coupled agarose beads, resulting in minimal background and exceptional specificity—critical for reliable downstream analyses.

    Key advantages of this antibody include:

    • Versatility: Suitable for immunocytochemistry/immunofluorescence (ICC/IF), immunohistochemistry (IHC) on frozen and paraffin sections, flow cytometry, and ELISA.
    • Signal Amplification: Multiple binding events per primary antibody enable robust fluorescence signal amplification, enhancing sensitivity for low-abundance targets.
    • Stability & Handling: Supplied at 1 mg/mL in a stabilizing buffer, it's protected from degradation and photobleaching when stored at -20°C, aliquoted, and shielded from light.

    Step-by-Step Workflow: Protocol Enhancements with Cy3 Rabbit Anti-Goat IgG (H+L) Antibody

    1. Primary Antibody Incubation

    After antigen retrieval and blocking (e.g., with 1% BSA in PBS), incubate samples with a goat-derived primary antibody. Optimal dilution is assay-dependent—typical ranges are 1:100–1:1000 for IHC/ICC, as established in studies like Precision Signal Amplification.

    2. Washing Steps

    Perform three washes in PBS with 0.05% Tween-20 to minimize non-specific binding. Stringent washes are especially crucial in IHC on paraffin-embedded tissues.

    3. Cy3-Conjugated Secondary Antibody Application

    Apply the Cy3 Rabbit Anti-Goat IgG (H+L) Antibody at a typical dilution of 1:500 for ICC/IF and IHC. For flow cytometry and ELISA, titration is recommended to maximize signal-to-noise ratio. Incubate for 1 hour at room temperature in the dark to protect the fluorophore.

    4. Secondary Washing & Mounting

    Wash samples thoroughly to remove unbound secondary antibody. For microscopy, mount with an anti-fade medium to preserve Cy3 fluorescence. For flow cytometry, resuspend cells in PBS and analyze immediately.

    5. Data Acquisition & Quantification

    Capture fluorescence using appropriate filter sets (Cy3: Ex 550–560 nm/Em 570–580 nm). Quantify signal using image analysis software or flow cytometry platforms. Studies consistently report a >4-fold increase in detection sensitivity compared to HRP or DAB-based methods (see Fluorescent Signal Robustness).

    Advanced Applications and Comparative Advantages

    Immunocytochemistry and Immunohistochemistry

    In translational oncology, especially prostate cancer biomarker discovery, sensitive detection of key regulatory proteins—such as those elucidated in the APOBEC3C suppression study—is paramount. The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody facilitates robust immunofluorescence detection of targets like STING1, Caspase1, and IL-18 in both cell lines and tissue biopsies. Its low background is ideal for multiplexing and co-localization studies, enabling discrimination of subtle expression differences among tumor stages.

    Flow Cytometry

    As a secondary antibody for flow cytometry, the Cy3 Rabbit Anti-Goat IgG (H+L) Antibody permits precise quantification of surface or intracellular markers. Compared to directly labeled primaries, this approach amplifies signal, critical in low-expressing populations such as tumor-infiltrating lymphocytes. Peer-reviewed workflows report a 2- to 3-fold improvement in population resolution (see Unlocking Precision Detection).

    ELISA Detection

    In secondary antibody for ELISA detection applications, Cy3 fluorescence offers superior dynamic range and lower detection limits versus enzymatic colorimetric substrates. This is especially valuable for quantifying cytokines like IL-1β and IL-18 in tumor microenvironment profiling.

    Comparative Performance and Competitive Landscape

    Compared to Alexa Fluor or FITC-conjugated alternatives, Cy3 delivers a balanced combination of brightness, photostability, and compatibility with multiplex panels, reducing spectral overlap. In head-to-head benchmarking, Cy3-labeled secondaries consistently produced higher signal-to-background ratios in both fixed and live-cell imaging (Amplifying Translational Oncology).

    Troubleshooting and Optimization Tips

    • Minimizing Background: Always block with 1% BSA or normal serum from the host species of the secondary antibody. Avoid using goat serum when detecting goat primaries to prevent competitive inhibition.
    • Protecting Fluorescence: Minimize light exposure during and after staining. Store antibody aliquots at -20°C in the dark; avoid repeated freeze-thaw cycles, as recommended by APExBIO.
    • Optimizing Antibody Dilution: Titrate both primary and secondary antibodies for each new lot or assay type. Over-concentration can increase background, while under-concentration reduces sensitivity.
    • Sample Preparation: For IHC-P, ensure complete deparaffinization and antigen retrieval. For ICC, use gentle fixation (e.g., 4% PFA) to preserve antigenicity.
    • Multiplexing: When using multiple fluorophores, carefully select secondary antibodies from different species and choose dyes with minimal spectral overlap.
    • Controls: Include no-primary controls and isotype controls to assess non-specific binding. In flow cytometry, single-stain controls are essential for compensation.

    For a deeper dive into real-world troubleshooting, Optimizing Cell Assays comprehensively addresses scenario-specific issues such as autofluorescence, cross-reactivity, and batch variability, complementing the protocol enhancements discussed here.

    Future Outlook: Enabling Next-Generation Immunodetection

    As cancer research pivots toward high-plex, spatially resolved, and single-cell analyses, the demand for secondary antibodies that combine specificity, sensitivity, and multiplex compatibility will only intensify. The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody’s track record in translational workflows—such as those profiling the molecular regulators of prostate cancer progression—positions it as an essential tool for the next wave of biomarker discovery and immunotherapeutic development.

    Emerging applications include:

    • Spatial Omics: Integration with in situ sequencing and spatial transcriptomics for mapping protein and RNA expression in the same specimen.
    • Super-resolution Imaging: Compatibility with STED and SIM microscopy to resolve subcellular protein localization at nanometer scales.
    • High-throughput Screening: Automation-ready protocols for drug discovery platforms requiring robust, reproducible signal amplification.

    In summary, the Cy3 Rabbit Anti-Goat IgG (H+L) Antibody, supplied by APExBIO, delivers the performance, reproducibility, and adaptability demanded by cutting-edge research in oncology and immunology. Its proven role in landmark studies, such as the recent analysis of APOBEC3C’s suppressive mechanisms in prostate cancer, underscores its value for both routine and translational immunodetection tasks.